vs

Side-by-side financial comparison of AMPCO PITTSBURGH CORP (AP) and CareDx, Inc. (CDNA). Click either name above to swap in a different company.

CareDx, Inc. is the larger business by last-quarter revenue ($117.7M vs $104.4M, roughly 1.1× AMPCO PITTSBURGH CORP). CareDx, Inc. runs the higher net margin — 2.4% vs -55.2%, a 57.6% gap on every dollar of revenue. On growth, CareDx, Inc. posted the faster year-over-year revenue change (39.0% vs 11.5%). CareDx, Inc. produced more free cash flow last quarter ($514.0K vs $-64.0K). Over the past eight quarters, CareDx, Inc.'s revenue compounded faster (12.9% CAGR vs -2.6%).

Ampco-Pittsburgh Corporation is a specialty steel manufacturer headquartered in Downtown Pittsburgh, Pennsylvania. It is one of several companies to bear the Ampco name, and it should not be confused with the Milwaukee-based copper base alloy producer, Ampco Metal Inc.; the Miami-based cabinetry company; the Swiss aluminum corporation; or the Dallas-based tool company. Ampco was formed in 1929 and is a conglomerate made up of several previously established small steel makers. Five small compa...

CareDx, Inc. is a leading precision medicine company dedicated to organ transplant patient care. It develops and commercializes diagnostic tests for rejection surveillance, digital health management tools, and supportive clinical services, catering to transplant clinicians, patients, and healthcare systems across North America and European core markets.

AP vs CDNA — Head-to-Head

Bigger by revenue
CDNA
CDNA
1.1× larger
CDNA
$117.7M
$104.4M
AP
Growing faster (revenue YoY)
CDNA
CDNA
+27.5% gap
CDNA
39.0%
11.5%
AP
Higher net margin
CDNA
CDNA
57.6% more per $
CDNA
2.4%
-55.2%
AP
More free cash flow
CDNA
CDNA
$578.0K more FCF
CDNA
$514.0K
$-64.0K
AP
Faster 2-yr revenue CAGR
CDNA
CDNA
Annualised
CDNA
12.9%
-2.6%
AP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AP
AP
CDNA
CDNA
Revenue
$104.4M
$117.7M
Net Profit
$-57.7M
$2.8M
Gross Margin
Operating Margin
-54.0%
1.0%
Net Margin
-55.2%
2.4%
Revenue YoY
11.5%
39.0%
Net Profit YoY
-1958.9%
EPS (diluted)
$-2.87
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AP
AP
CDNA
CDNA
Q1 26
$117.7M
Q4 25
$104.4M
$108.4M
Q3 25
$103.7M
$100.1M
Q2 25
$108.9M
$86.7M
Q1 25
$99.2M
$84.7M
Q4 24
$93.6M
$86.6M
Q3 24
$92.1M
$82.9M
Q2 24
$107.1M
$92.3M
Net Profit
AP
AP
CDNA
CDNA
Q1 26
$2.8M
Q4 25
$-57.7M
$-4.1M
Q3 25
$-2.2M
$1.7M
Q2 25
$-7.3M
$-8.6M
Q1 25
$1.1M
$-10.4M
Q4 24
$3.1M
$87.7M
Q3 24
$-2.0M
$-10.6M
Q2 24
$2.0M
$-4.6M
Operating Margin
AP
AP
CDNA
CDNA
Q1 26
1.0%
Q4 25
-54.0%
-5.6%
Q3 25
1.1%
-0.2%
Q2 25
-2.8%
-12.8%
Q1 25
3.9%
-15.8%
Q4 24
5.5%
97.5%
Q3 24
2.0%
-16.6%
Q2 24
4.7%
-7.9%
Net Margin
AP
AP
CDNA
CDNA
Q1 26
2.4%
Q4 25
-55.2%
-3.8%
Q3 25
-2.1%
1.7%
Q2 25
-6.7%
-9.9%
Q1 25
1.2%
-12.2%
Q4 24
3.3%
101.3%
Q3 24
-2.1%
-12.8%
Q2 24
1.9%
-5.0%
EPS (diluted)
AP
AP
CDNA
CDNA
Q1 26
$0.05
Q4 25
$-2.87
$-0.08
Q3 25
$-0.11
$0.03
Q2 25
$-0.36
$-0.16
Q1 25
$0.06
$-0.19
Q4 24
$0.16
$1.60
Q3 24
$-0.10
$-0.20
Q2 24
$0.10
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AP
AP
CDNA
CDNA
Cash + ST InvestmentsLiquidity on hand
$10.7M
$77.9M
Total DebtLower is stronger
$117.9M
Stockholders' EquityBook value
$32.6M
Total Assets
$495.4M
$411.1M
Debt / EquityLower = less leverage
3.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AP
AP
CDNA
CDNA
Q1 26
$77.9M
Q4 25
$10.7M
$177.2M
Q3 25
$15.0M
$194.2M
Q2 25
$9.9M
$186.3M
Q1 25
$7.1M
$230.9M
Q4 24
$15.4M
$260.7M
Q3 24
$11.8M
$240.9M
Q2 24
$7.9M
$228.9M
Total Debt
AP
AP
CDNA
CDNA
Q1 26
Q4 25
$117.9M
Q3 25
$119.0M
Q2 25
$115.9M
Q1 25
$115.0M
Q4 24
$116.4M
Q3 24
$116.0M
$0
Q2 24
$119.4M
$0
Stockholders' Equity
AP
AP
CDNA
CDNA
Q1 26
Q4 25
$32.6M
$303.1M
Q3 25
$60.1M
$311.1M
Q2 25
$62.7M
$327.4M
Q1 25
$64.6M
$379.3M
Q4 24
$58.9M
$378.4M
Q3 24
$61.3M
$273.2M
Q2 24
$58.0M
$264.7M
Total Assets
AP
AP
CDNA
CDNA
Q1 26
$411.1M
Q4 25
$495.4M
$413.2M
Q3 25
$524.4M
$432.3M
Q2 25
$537.2M
$444.3M
Q1 25
$536.2M
$489.6M
Q4 24
$530.9M
$491.1M
Q3 24
$547.4M
$477.0M
Q2 24
$560.8M
$466.8M
Debt / Equity
AP
AP
CDNA
CDNA
Q1 26
Q4 25
3.61×
Q3 25
1.98×
Q2 25
1.85×
Q1 25
1.78×
Q4 24
1.98×
Q3 24
1.89×
0.00×
Q2 24
2.06×
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AP
AP
CDNA
CDNA
Operating Cash FlowLast quarter
$2.7M
$4.3M
Free Cash FlowOCF − Capex
$-64.0K
$514.0K
FCF MarginFCF / Revenue
-0.1%
0.4%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
1.54×
TTM Free Cash FlowTrailing 4 quarters
$-8.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AP
AP
CDNA
CDNA
Q1 26
$4.3M
Q4 25
$2.7M
$21.4M
Q3 25
$6.3M
$37.4M
Q2 25
$-2.3M
$9.9M
Q1 25
$-5.3M
$-26.6M
Q4 24
$7.5M
$21.9M
Q3 24
$11.4M
$12.5M
Q2 24
$-5.3M
$18.9M
Free Cash Flow
AP
AP
CDNA
CDNA
Q1 26
$514.0K
Q4 25
$-64.0K
Q3 25
$3.3M
Q2 25
$-3.8M
Q1 25
$-7.5M
Q4 24
$3.7M
Q3 24
$8.4M
Q2 24
$-8.0M
FCF Margin
AP
AP
CDNA
CDNA
Q1 26
0.4%
Q4 25
-0.1%
Q3 25
3.2%
Q2 25
-3.5%
Q1 25
-7.5%
Q4 24
4.0%
Q3 24
9.1%
Q2 24
-7.5%
Capex Intensity
AP
AP
CDNA
CDNA
Q1 26
Q4 25
2.7%
Q3 25
2.9%
Q2 25
1.3%
Q1 25
2.2%
Q4 24
4.0%
Q3 24
3.2%
Q2 24
2.5%
Cash Conversion
AP
AP
CDNA
CDNA
Q1 26
1.54×
Q4 25
Q3 25
22.30×
Q2 25
Q1 25
-4.62×
Q4 24
2.40×
0.25×
Q3 24
Q2 24
-2.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AP
AP

Forged And Cast Mill Rolls$67.0M64%
Air Handling Systems$14.3M14%
Heat Exchange Coils$13.1M13%
Centrifugal Pumps$10.3M10%
Forged Engineered Products$4.0M4%

CDNA
CDNA

Financial Results Total$85.0M72%
Patient and digital solutions revenue$16.0M14%
Product revenue$10.3M9%
Other$6.4M5%

Related Comparisons